Clinical application and standardized implementation of intersphincteric resection.
10.3760/cma.j.cn441530-20230228-00056
- Author:
Pan CHI
1
;
Xiao Jie WANG
1
Author Information
1. Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou 350001, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Rectal Neoplasms/pathology*;
Postoperative Complications;
Laparoscopy/methods*;
Anal Canal/pathology*;
Anus Neoplasms/pathology*;
Anus Diseases/surgery*;
Low Anterior Resection Syndrome;
Carcinoma, Signet Ring Cell/pathology*;
Treatment Outcome
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(6):548-556
- CountryChina
- Language:Chinese
-
Abstract:
Intersphincteric resection (ISR) is the ultimate sphincter-preserving surgical technique for low rectal cancer. To promote the standardized implementation of ISR, this review discusses the important issues regarding the clinical application of ISR with reference to the latest Chinese expert consensus on ISR. In terms of ISR-related pelvic anatomy of the rectum/anal canal, hiatal ligament is not identical with the anococcygeal ligament. At the level where the rectourethralis muscle continuously extends to the posteroinferior area of the membranous urethra from the rectum, the neurovascular bundle is identified between the posterior edge of rectourethralis muscle and the anterior edge of the longitudinal muscle of the rectum. This knowledge is crucial to detect the anterior dissection plane during ISR at the levator hiatus level. The indication criteria for ISR included: (1) stage I early low rectal cancer; (2) stage II-III low rectal cancer undergoing neoadjuvant treatment, and supra-anal tumors and juxta-anal tumors of stage ycT3NxM0, or intra-anal tumors of stage ycT2NxM0. However, signet ring cell carcinoma, mucinous adenocarcinoma and undifferentiated carcinoma should be contraindicated to ISR. For locally advanced low rectal cancer (especially anteriorly located tumor), neoadjuvant treatment should be carried out in a standardized manner. However, it should be recognized that neoadjuvant chemoradiotherapy was a risk factor for poor anal function after ISR. For surgical approaches for ISR, including transanal, transabdominal, and transanal transabdominal approaches, the choice should be based on oncological safety and functional consequences. While ensuring the negative margin, maximal preservation of rectal walls and anal canal contributs to better postoperative anorectal function. Careful attention must be paid to complications regarding ISR, with special focus on the anastomotic complications. The incidence of low anterior resection syndrome (LARS) was higher than 40%. However, this issue is often neglected by clinicians. Thus, management and rehabilitation strategies for LARS with longer follow-ups were required.
